Latest filing published 26 Mar 2015 for Akamai Technologies INC.
No signal scores available.
Martin M. Coyne II discloses dealings in 2 companies, chiefly Akamai Technologies Inc and Bio Imaging Technologies Inc. Over a trading history stretching from 10 May 2006 to 24 March 2015, the count stands at 37 filings.
Sales make up the whole of the open-market record (18 sales, €3.4M). Other entries cover 18 option exercises.
On 26 March 2015 came the latest disclosure, an option exercise in Akamai Technologies Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 37 declarations